Government News

- Read more about FSSAI notify first amendments on regulations on Food Safety and Standards (Import)
FSSAI has notified the Food Safety and Standards (Import) First Amendment Regulations, 2018.

This notification amends the requirement relating to
a. shelf life of imported product at the time of port clearance. As per this notification, Custom Authorities shall not clear any article of food unless it has a valid shelf life of not less than sixty per cent, or three months before expiry, whichever is less, at the time of import”
b. Further, one more provision stating “the importer shall submit certificate of sanitary export from authorized agencies in exporting countries for the categories of food as may be specified by the Food Authority from time to time” has also been inserted. This will help in the risk prioritization and in effectively dealing with high risk products intended for import.
- Read more about FDA permit the use of Trevo clot retrieval devices to treat certain stroke patients
The U.S. Food and Drug Administration cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24 hours after symptom onset, expanding the device’s indication to a broader group of patients.
- Read more about Retail prices of nine formulations under Drugs Prices Control Order, 2013 get fixed by NPPA
As per notification dated 13 February 2018, NPPA fix retail prices of 9 formulations under Drugs Prices Control Order, 2013.
- Read more about India Pharma & India Medical Device 2018 started today in Bengaluru
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce & Industry (FICCI), is organizing ‘India Pharma & India Medical Device 2018’, with the theme - ‘Affordable and Quality Healthcare’, the 3rd International exhibition and conference on Pharmaceutical & Medical Device sector from 15th-17th February, 2018 in Bengaluru.

(adsbygoogle = window.adsbygoogle || []).push({});
- Read more about USTR requested to remove India from Priority Watch List
The increasing commercial collaboration between U.S. and Indian pharmaceutical companies is indicative of the ways in which U.S. companies are increasing their revenues from India and spreading their development costs. In view of such several development points, Indian pharma body urged U.S. Trade Representative (USTR) to remove India from Priority Watch List.
- Read more about DGHS orders port offices to release imported Insulin formulations
Directorate General of Health Services (DGHS) Office of Drugs Controller General (India) orders port offices to release all the consignments of imported Insulin formulations including consignments released on letter to avoid shortage of such lifesaving drugs.
- Read more about HIV Rate declining by 66% in India
There has been a 66% decline in the estimated number of annual new HIV infections in the country from 2000 to 2015, against the global average of 35%.
- Read more about Per Capita healthcare expenditure is reduced in 2017 : Health Ministry
As per National Health Accounts Estimates for India 2014-15, the total health expenditure per capita is estimated to be Rs. 3826.
- Read more about Smt. Anupriya Patel Minister of State for Health and Family Welfare reviews the activities of National Centre for Disease Control
Smt. Anupriya Patel, Minister of State for Health and Family Welfare reviewed the activities of National Centre for Disease Control and issued necessary directions for disease surveillance, monitoring of health status, educating the public, providing evidence for public health action and enforcing public health regulations. She also visited the Epidemiology & Disease Control Complex and interacted with India Epidemic Intelligence Service (EIS) officers undergoing two years training at NCDC in collaboration with CDC Atlanta under Global Health Security Agenda (GHSA). During her visit at the Strategic Health Operations Centre (SHOC), the MoS (Health) reviewed the Seasonal Influenza (H1N1) status through video conferencing with the States of Rajasthan, Gujarat and Uttar Pradesh.
- Read more about No impact on prices of Essential Drugs post introduction of GST in India
It is noticed that that there will be almost no impact on the prices of non-scheduled formulations which account for nearly 80% of the total pharmaceuticals sector, analysed by government.